Ukraine's Cabinet of Ministers has published a resolution introducing reference prices of some medicines from January 1, 2017 and their reimbursement from April 1, 2017.

Government resolution No. 862 on the regulation of prices of medicines and resolution No. 863 introducing reimbursement of the cost of medicines were posted on the government's website on Tuesday.

As reported, the government has approved a resolution introducing reference prices for medicines to treat cardiovascular diseases, diabetes and bronchial asthma from January 1, 2017 and launching the reimbursement program for them from April 1, 2017.

The price regulation would concern medicines included in the national list of major medicines and the international nonproprietary name (INN) list. The cost of these medicines is to be reimbursed.

The upper marketing markup for medicines that the state reimburses partially or in full is 5% and the upper retail markup with all taxes and duties is 15%.

The price of medicines in Poland, Latvia, Slovakia, Hungary and the Czech Republic are used to calculated reference prices of INN.

The reimbursement program for cardiovascular diseases includes 16 INN, for bronchial asthma – three INN and diabetes mellitus – two INN.